La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PubMed)

Index « Auteurs » - entrée « P. Rondot »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
P. Rogelet < P. Rondot < P. Ryvlin  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
001356 (1998) C. Potagas [France] ; G. Dellatolas ; M. Ziegler ; J. Leveteau ; N. Bathien ; P. Mac Leod ; P. RondotClinical assessment of olfactory dysfunction in Parkinson's disease.
001627 (1992) A P Feve [France] ; N. Bathien ; P. RondotChronic administration of L-dopa affects the movement-related cortical potentials of patients with Parkinson's disease.
001630 (1992) P. Rondot [France] ; M. ZieglerActivity and acceptability of piribedil in Parkinson's disease: a multicentre study.
001632 (1991) A P Feve [France] ; N. Bathien ; P. Rondot[Changes in movement-related cortical potentials in Parkinson's patients before and after treatment with levodopa].
001633 (1991) P. Rondot [France]The shadow of movement.
001660 (1991) M O Habert [France] ; U. Spampinato ; J L Mas ; M L Piketty ; M C Bourdel ; J. De Recondo ; P. Rondot ; S. AskienazyA comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
001661 (1991) U. Spampinato [France] ; M O Habert ; J L Mas ; M C Bourdel ; M. Ziegler ; J. De Recondo ; S. Askienazy ; P. Rondot(99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.
001700 (1989) P. Rondot [France] ; M. Ziegler ; N. Aymard ; A. TeinturierEffect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.
001721 (1987) M. Ziegler [France] ; V. Fournier ; N. Bathien ; P L Morselli ; P. RondotTherapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
001728 (1987) P. Rondot [France] ; M. Ziegler ; N. Aymard ; J. HolzerClinical trial of Madopar HBS in parkinsonian patients with fluctuating drug response after long-term levodopa therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "P. Rondot" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "P. Rondot" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    P. Rondot
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024